| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Experimental Pathology [H. L. A., K. L. H., Y. D., F. N., B. B. A.] and Pathology [J. S. W.], Roswell Park Cancer Institute, Buffalo, New York 14263, and Department of Pathology, Beth Israel Hospital, Boston, Massachusetts 02215 [J. L. C.]
Down-regulation of gelsolin, an actin-binding protein, is frequently found in several types of transformed cells and tumors. The present study demonstrates that gelsolin protein and RNA were absent or markedly reduced in human breast cancer cell lines relative to "normal" mortal human mammary epithelial cells and benign, immortalized cell lines. Moreover, actin filaments were usually attenuated coincident with the reduction in gelsolin. Gelsolin was also missing or greatly decreased in 70% of 30 human sporadic, invasive breast carcinomas examined by immunocytochemistry and in 100% of virally induced mouse and chemically induced rat mammary carcinomas evaluated by Northern analysis. Southern analysis revealed no major mutations in the gelsolin gene of human breast cancer cells. Our results show that partial or total loss of gelsolin expression is common to the majority of breast cancers of diverse etiologies in three animal species and point to gelsolin as a candidate suppressor of breast cancer.
1 Supported by the Roswell Park Alliance Foundation and Grants CA56609 and CA62014 from the National Cancer Institute, NIH.
2 To whom requests for reprints should be addressed.
Received 8/ 8/96. Accepted 9/18/96.
This article has been cited by other articles:
![]() |
F. Vandermoere, I. E. Yazidi-Belkoura, Y. Demont, C. Slomianny, J. Antol, J. Lemoine, and H. Hondermarck Proteomics Exploration Reveals That Actin Is a Signaling Target of the Kinase Akt Mol. Cell. Proteomics, January 1, 2007; 6(1): 114 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, K. L. Knutson, E. Gad, and M. L. Disis The Tumor Antigen Repertoire Identified in Tumor-Bearing Neu Transgenic Mice Predicts Human Tumor Antigens Cancer Res., October 1, 2006; 66(19): 9754 - 9761. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Lu, Y.-S. Jin, A. Pantuck, Z.-F. Zhang, D. Heber, A. Belldegrun, M. Brooks, R. Figlin, and J. Rao Green Tea Extract Modulates Actin Remodeling via Rho Activity in an In vitro Multistep Carcinogenic Model Clin. Cancer Res., February 15, 2005; 11(4): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Qiu, G. V. R. Chandramouli, K. W. Hunter, N. W. Alkharouf, J. E. Green, and E. T. Liu Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-Transgenic Mice: Correlation to Human Disease Cancer Res., September 1, 2004; 64(17): 5973 - 5981. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ras Promotes Butyrate-induced Apoptosis through Inhibition of Gelsolin Expression J. Biol. Chem., August 27, 2004; 279(35): 36680 - 36688. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Soriano and J. D. Pardee M34 Actin Regulatory Protein Is a Sensitive Diagnostic Marker for Early- and Late-Stage Mammary Carcinomas Clin. Cancer Res., July 1, 2004; 10(13): 4437 - 4443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahman, H. Miyamoto, and C. Chang Androgen Receptor Coregulators in Prostate Cancer: Mechanisms and Clinical Implications Clin. Cancer Res., April 1, 2004; 10(7): 2208 - 2219. [Full Text] [PDF] |
||||
![]() |
N. Wittenmayer, B. Jandrig, M. Rothkegel, K. Schluter, W. Arnold, W. Haensch, S. Scherneck, and B. M. Jockusch Tumor Suppressor Activity of Profilin Requires a Functional Actin Binding Site Mol. Biol. Cell, April 1, 2004; 15(4): 1600 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tanaka, Y. Yan, J. Choi, J. Bai, V. A. Klenchin, I. Rayment, and G. Marriott Biomolecular mimicry in the actin cytoskeleton: Mechanisms underlying the cytotoxicity of kabiramide C and related macrolides PNAS, November 25, 2003; 100(24): 13851 - 13856. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nishimura, H.-J. Ting, Y. Harada, T. Tokizane, N. Nonomura, H.-Y. Kang, H.-C. Chang, S. Yeh, H. Miyamoto, M. Shin, et al. Modulation of Androgen Receptor Transactivation by Gelsolin: A Newly Identified Androgen Receptor Coregulator Cancer Res., August 15, 2003; 63(16): 4888 - 4894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benvenuti, R. Cramer, C. C. Quinn, J. Bruce, M. Zvelebil, S. Corless, J. Bond, A. Yang, S. Hockfield, A. L. Burlingame, et al. Differential Proteome Analysis of Replicative Senescence in Rat Embryo Fibroblasts Mol. Cell. Proteomics, April 1, 2002; 1(4): 280 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Martin and P. Leder Human MCF10A Mammary Epithelial Cells Undergo Apoptosis following Actin Depolymerization That Is Independent of Attachment and Rescued by Bcl-2 Mol. Cell. Biol., October 1, 2001; 21(19): 6529 - 6536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zunino, Q. Li, S. D. Rose, M. M. I. Romero-Benitez, T. Lejen, N. C. Brandan, and J.-M. Trifaro Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis Blood, October 1, 2001; 98(7): 2210 - 2219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Thor, S. M. Edgerton, S. Liu, D. H. Moore II, and D. J. Kwiatkowski Gelsolin as a Negative Prognostic Factor and Effector of Motility in erbB-2-positive Epidermal Growth Factor Receptor-positive Breast Cancers Clin. Cancer Res., August 1, 2001; 7(8): 2415 - 2424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Janke, K. Schluter, B. Jandrig, M. Theile, K. Kolble, W. Arnold, E. Grinstein, A. Schwartz, L. Estevez-Schwarz, P. M. Schlag, et al. Suppression of Tumorigenicity in Breast Cancer Cells by the Microfilament Protein Profilin 1 J. Exp. Med., May 8, 2000; 191(10): 1675 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Klampfer, J. Cammenga, H.-G. Wisniewski, and S. D. Nimer Sodium Salicylate Activates Caspases and Induces Apoptosis of Myeloid Leukemia Cell Lines Blood, April 1, 1999; 93(7): 2386 - 2394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kothakota, T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T. J. McGarry, M. W. Kirschner, K. Koths, D. J. Kwiatkowski, et al. Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis Science, October 10, 1997; 278(5336): 294 - 298. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |